Robotics

Researchers develop soft-packaged, portable rehabilitation glove

Researchers from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) have proposed a soft-packaged and portable rehabilitation glove with fine movement training. It is expected ...

Electronics & Semiconductors

How much faster can computers get?

A group of 10 universities led by the University of California, San Diego is undertaking a $50.5 million effort to greatly improve the speed and efficiency of computers, work that could do everything from make drug discovery ...

Machine learning & AI

Advancing dynamic brain imaging with AI

MRI, electroencephalography (EEG) and magnetoencephalography have long served as the tools to study brain activity, but new research from Carnegie Mellon University introduces a novel, AI-based dynamic brain imaging technology ...

Computer Sciences

A math model to predict COVID-19 vaccine efficacy

COVID-19 vaccines have been a game-changer in the current pandemic. Several vaccine candidates have conferred a high degree of protection, with some reducing the number of symptomatic infections by over 95% in clinical trials. ...

page 1 from 4

Clinical trial

In clinical trials are conducted to allow safety and efficacy data to be collected for new drugs or devices. These trials can only take place once satisfactory information has been gathered on the quality of the product and its non-clinical safety, and Health Authority/Ethics Committee approval is granted in the country where the trial is taking place.

Depending on the type of product and the stage of its development, investigators enroll healthy volunteers and/or patients into small pilot studies initially, followed by larger scale studies in patients that often compare the new product with the currently prescribed treatment. As positive safety and efficacy data are gathered, the number of patients is typically increased. Clinical trials can vary in size from a single center in one country to multicenter trials in multiple countries.

Due to the sizable cost a full series of clinical trials may incur, the burden of paying for all the necessary people and services is usually borne by the sponsor who may be the pharmaceutical or biotechnology company that developed the agent under study. Since the diversity of roles may exceed resources of the sponsor, often a clinical trial is managed by an outsourced partner such as a contract research organization

This text uses material from Wikipedia, licensed under CC BY-SA